Susan Ou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Susan Ou has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexander A. Cohen
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
1 shared publication - Anthony P. West
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA
1 shared publication Christopher O. Barnes
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
1 shared publication- Hung‐Jen Wu
Department of Biochemistry University of Oxford South Parks Road Oxford OX1 3QU UK
1 shared publication - Jennifer R. Keeffe
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
1 shared publication - Leesa M. Kakutani
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 735-741
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Fighting zoonotic coronaviruses: In the past 20 years, three betacoronaviruses thought to have originated in bats have caused devastating disease in humans. The global pandemic caused by the latest such virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the need to protect against other strains that could present a threat to humans. Cohen et al. constructed nanoparticles displaying the protein domain that binds the host cell receptor (receptor-binding domain or RBD), either a homotypic SARS-CoV-2 particle or mosaic particles displaying RBDs from four or eight different betacoronaviruses. In mice, antibodies to the SARS-CoV-2 RBD were elicited just as well by mosaic particles as by homotypic nanoparticles. The mosaic nanoparticles elicited antibodies that, beyond recognizing the strains displayed, also recognized mismatched strains. Science , this issue p. 735
- 12 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6530) , 735-741
Top Cited PapersOpen AccessMosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Fighting zoonotic coronaviruses: In the past 20 years, three betacoronaviruses thought to have originated in bats have caused devastating disease in humans. The global pandemic caused by the latest such virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the need to protect against other strains that could present a threat to humans. Cohen et al. constructed nanoparticles displaying the protein domain that binds the host cell receptor (receptor-binding domain or RBD), either a homotypic SARS-CoV-2 particle or mosaic particles displaying RBDs from four or eight different betacoronaviruses. In mice, antibodies to the SARS-CoV-2 RBD were elicited just as well by mosaic particles as by homotypic nanoparticles. The mosaic nanoparticles elicited antibodies that, beyond recognizing the strains displayed, also recognized mismatched strains. Science , this issue p. 735